Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) today announced that Tom Civik, President and Chief Executive Officer, and Helen Collins, M.D., Executive Vice President and Chief Medical Officer are scheduled to participate in a fireside chat at the Cowen 41st Annual Health Care Conference on Thursday, March 4, 2021 at 10:30 a.m.
- Five Prime Therapeutics, Inc. (NASDAQ: FPRX) today announced that Tom Civik, President and Chief Executive Officer, and Helen Collins, M.D., Executive Vice President and Chief Medical Officer are scheduled to participate in a fireside chat at the Cowen 41st Annual Health Care Conference on Thursday, March 4, 2021 at 10:30 a.m.
- Live audio webcast of the presentation will be accessible and available for replay from the Events & Presentations section of the Companys website at: http://investor.fiveprime.com/events.cfm .
- Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.
- Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development.